Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Willie Earley, MD
Allergan
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
85 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Forest Investigative Site 033
San Juan, Puerto Rico
- Forest Investigative Site 034
San Juan, Puerto Rico
- Forest Investigative Site 032
Tucson, Arizona, United States
- Forest Investigative Site 018
Little Rock, Arkansas, United States
- Forest Investigative Site 029
Little Rock, Arkansas, United States
- Forest Investigative Site 084
Cerritos, California, United States
- Forest Investigative Site 085
Culver City, California, United States
- Forest Investigative Site 082
Garden Grove, California, United States
- Forest Investigative Site 022
Newport Beach, California, United States
- Forest Investigative Site 004
Oceanside, California, United States
- Forest Investigative Site 090
Rancho Mirage, California, United States
- Forest Investigative Site 078
Redlands, California, United States
- Forest Investigative Site 080
Redlands, California, United States
- Forest Investigative Site 007
San Diego, California, United States
- Forest Investigative Site 054
San Diego, California, United States
- Forest Investigative Site 031
Temecula, California, United States
- Forest Investigative Site 048
Denver, Colorado, United States
- Forest Investigative Site 037
Coral Springs, Florida, United States
- Forest Investigative Site 053
Fort Myers, Florida, United States
- Forest Investigative Site 023
Hallandale, Florida, United States
- Forest Investigative Site 071
Hialeah, Florida, United States
- Forest Investigative Site 006
Leesburg, Florida, United States
- Forest Investigative Site 026
Miami, Florida, United States
- Forest Investigative Site 075
Miami, Florida, United States
- Forest Investigative Site 027
North Miami, Florida, United States
- Forest Investigative Site 074
North Miami, Florida, United States
- Forest Investigative Site 036
Oakland Park, Florida, United States
- Forest Investigative Site 051
Orlando, Florida, United States
- Forest Investigative Site 044
South Miami, Florida, United States
- Forest Investigative Site 008
Tampa, Florida, United States
- Forest Investigative Site 019
Winter Park, Florida, United States
- Forest Investigative Site 024
Atlanta, Georgia, United States
- Forest Investigative Site 060
Atlanta, Georgia, United States
- Forest Investigative Site 017
Marietta, Georgia, United States
- Forest Investigative Site 047
Smyrna, Georgia, United States
- Forest Investigative Site 070
Chicago, Illinois, United States
- Forest Investigative Site 013
Hoffman Estates, Illinois, United States
- Forest Investigative Site 063
Libertyville, Illinois, United States
- Forest Investigative Site 062
Maywood, Illinois, United States
- Forest Investigative Site 072
Naperville, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Nov 2012
- Primary completion
- 24 Jun 2016
- Completion
- 24 Jun 2016
- Last update posted
- 28 Aug 2019
- Registered enrollment
- 1,022
- Registry id
- NCT01715805
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.